GW25-e0557 Effects of Atorvastatin on Pregnancy Associated Plasma Protein-A Level in Vascular Smooth Muscle Cells Induced by Oxidized-low Density Lipoprotein  by Weiyi, Mei et al.
Objectives: As the most common sustained cardiac arrhythmia, atrial ﬁbrillation (AF)
is regarded as a heritable disease partially. Most former researches were concentrated
in heterozygous mutations or single nucleotide polymorphisms (SNPs) in the exon
coding regions. The relationship between AF occurrence and SNPs in nonprotein-
coding micro-RNAs is still mysterious. Our study focused on this ﬁled.
Methods: A total of 123 participants were enrolled from genetically unrelated ethnic
Han Chinese living in Nantong city of Jiangsu Province. 65 atrial ﬁbrillation patients
(Male: 53.85%; Age: 69.7513.44) were conﬁrmed with electrocardiogram or Holter,
58 normal individuals (Male: 48.28%; Age: 63.3614.11) were assigned to control
group. Genotypes of the pre-miRNA SNP rs11614913 in miR-196a2 were distin-
guished using the method of polymerase chain reaction-restriction fragment length
polymorphism (PCR-RFLP) assay. The primers used for ampliﬁcation were 5’-TCCA
GATAGATGCAAAGCTGAA-3’ (forward) and 5’-ATAGGTTGAGAGGACGGCA
TAA-3’ (reverse). PCR products were digested by speciﬁc restriction enzyme
Hpy188I, and then separated by 2% agarose gel electrophoresis. For hsa-mir-196a2
rs11614913 C/T, allele T is cuttable, yielding two fragments of 81 bp and 219 bp,
allele C is uncuttable and the fragment is still 300 bp. Hardy-Weinberg equilibrium
were evaluated by chi-square test. Student’s t test for continuous variables and
chi-square test for categorical variables were used. Odds ratio (OR) and 95% conﬁ-
dence intervals (CI) were reported to estimate the associations between genotypes and
AF risk using logistic regression analyses. Differences were considered statistically
signiﬁcant at P<0.05.
Results: The genotype frequencies were 15.4% (TT), 46.1% (TC), and 38.5% (CC)
for the AF patients, while 39.7% (TT), 46.5% (TC), and 13.8% (CC) for the control
participants. Signiﬁcantly increased AF risk was found to be associated with C allele
(P<0.0001; OR, 2.716; 95% CI, 1.620-4.553). Compared with miR-196a2
rs11614913 wild-type homozygote TT, signiﬁcantly increased AF risks exist in
variant homozygote CC (OR, 8.625; 95% CI, 2.939-25.316) and heterozygote TC
(OR, 2.556; 95% CI, 1.032-6.326). After Adjusting for age and sex, participants
with TC/CC genotypes still show high risk for AF statistically (OR, 3.614; 95% CI,
1.537-8.497).
Conclusions: Our study provides the ﬁrst evidence that the SNP rs11614913 in miR-
196a2 may be associated with increased risk of atrial ﬁbrillation in Han Chinese
population. It may be used as candidate biomarker for AF susceptibility.
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Objectives: Qiliqiangxin (QL), a traditional Chinese medicine, had long been used to
treat chronic heart failure. Recent studies revealed that differentiation of cardiac
ﬁbroblasts (CFs) into myoﬁbroblasts played an important role in cardiac remodeling
and development of heart failure, however little was known about whether QL
ameliorated myocardial remodeling via regulating CFs differentiation. The present
study aimed to investigate the effects of QL on angiotensin II (AngII)-induced CFs
transdifferentiation and the underlying mechanism.
Methods: Study was performed on in vitro cultured CFs from Sprague-Dawley rats.
Cells were stimulated by AngII (100nM) for 24 h in the presence and absence of
pretreatment with QL (0.5mg/ml) or Olmesartan (OLM 10nmol/L). Small-interfering
RNA (siRNA) was used to knockdown interleukin-6 (IL-6). CFs transdifferentiation
was examined by the expression of transforming growth factor-b1 (TGF-b1),
a-smooth muscle actin (a-SMA), IL-6, collagen typeI and typeIII.
Results: Results showed that AngII induced signiﬁcant increases of TGF-b1 and
a-SMA in CFs, which could be attenuated by QL, or by blocking AT1 receptor with
OLM. In addition, AngII-induced upregulation of IL-6 was reduced by QL, and
knocking down of IL-6 in CFs also suppressed the expression of AngII-induced TGF-
b1 and a-SMA, suggesting QL-mediated downregulation of IL-6 might be centrally
involved in AngII-induced CFs transdifferentiation. Further data showed that
enhanced type I and type III collagens in response to AngII were inhibited by QL,
OLM or IL-6-siRNA.
Conclusions: These data provided evidence that CFs transdifferentiation could be
reversed by QL through regulating IL-6 signaling.
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Objectives: Both pregnancy-associated plasma protein A (PAPP-A) and vascular
smooth muscle cells (VSMCs) play roles in the development of atherosclerosis (AS). In
this study, we investigated the effect of atorvastatin on PAPP-A level inVSMCs induced
by oxidized-low density lipoprotein (ox-LDL) and its potential mechanism in AS.
Methods: Different concentrations of ox-LDL (75, 150, 300mg/ml) were added into
the culture medium for different processing time (2, 12 and 24h) to induce rat VSMCsC48 JACC Vol 64/16/Suppl C j Octoboxidative injury model. The level of PAPP-A mRNA and protein were evaluated by
RT-PCR and Western Blotting. Then we observed the change in PAPP-A mRNA and
protein expression after treatment with atorvastatin.
Results: Compared with control group, PAPP-A mRNA and protein levels increased
in a dose and time-dependent manner when VSMCs were induced by ox-LDL. After
exposure to ox-LDL (300 mg/ml) for 12 and 24h, PAPP-A mRNA and protein levels
were dramatically increased (P<0.01). However, PAPP-A mRNA and protein levels
were strongly decreased after atorvastatin treatment.
Conclusions: Atorvastatin can regulate the expression of PAPP-A mRNA and protein
induced by ox-LDL, which demonstrate that PAPP-A is probably involved in the anti-
As mechanism of atorvastatin.
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Objectives: Toll-like receptor 4 participates in the process of acute heart injury. The
underlying mechanisms of its protection are multi-factorial, but we hypothesized that
Toll-like receptor-mediated autophagy control plays a vital role. The purpose of this
study was to clarify the effect of autophagy on cardiac ﬁbrosis.
Methods: Cardiac ﬁbrosis was induced by subcutaneous isoproterenol (ISO) injec-
tion, and rapamycin was simultaneously administered orally for 14 days. Animal
echocardiography was then used to evaluate the success of the cardiac ﬁbrosis model,
and the mice were sacriﬁced after the echocardiography examination.
Results: Toll-like receptor-4 knockout (TLR4 KO) mice had better heart function than
did wild-type (WT) mice (P<0.05). Rapamycin treatment reduced the left ventricular
ejection fraction to 23.5% (P<0.05), and the collagen volume fraction of the ISO and
ISO plus rapamycin groups was 5.9% and 25.9%, respectively, in TLR4 KO mice.
Compared with the WT mice, Beclin1 and autophagy were downregulated in TLR4
KO mice (P<0.05); however, the ISO plus rapamycin group had higher autophagy
activity than did the ISO group in TLR4 KO mice (P<0.05).
Conclusions: Our results suggest that TLR4 knockout-induced cardioprotection against
isoproterenol-induced cardiac ﬁbrosis is associated with reduced autophagy induction.
Cardiac ﬁbroblast autophagy participates in its own activation. The moderate inhibition
of autophagic activity may be a new strategy for treating cardiac ﬁbrosis.
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Objectives: Circulating endothelial microparticles (EMPs) are recently suggested as a
promising biomarker of endothelial function and target for cardiovascular disorders.
However, increased studies reported that the biological effects of EMPs are ambiva-
lent. The objective of this study is to identify proteins differentially expressed between
patients with coronary artery disease (CAD) and control subjects.
Methods: Different EMPs populations were generated from patients (n¼5) with CAD
and control subjects (n¼5) for proteomic analysis by LC/MS. For the in vitro
assessment, differential gene expression of identiﬁed proteins was validated by RT-
PCR in HUVECs stimulated with TNF-a or ox-LDL. For further conﬁrmation of
candidate proteins in vivo, a total of 82 patients with CAD and 36 age- and sex-
matched healthy controls were recruited. Detection of identiﬁed proteins in serum was
carried out with ELISA.
Results: By applying proteomic analysis, two proteins, namely, keratin and ankyrin
repeat domain 1 protein (ANKRD1), were suggested as candidates. For further identi-
ﬁcation, exposure of HUVEC to TNF-a or ox-LDL up-regulated the expression of the
mRNA levels of keratin and ANKRD1 in a concentration-dependent manner respec-
tively (P<0.05). As for the in vivo experiment, keratin levels in the patients of acute
coronary syndromes (ACS) and stable angina pectoris (SAP) groups were signiﬁcantly
higher than those of the control group (P<0.05), while ANKRD1 could distinguish
patients with ACS from patients with SAP and control subjects, respectively.
Conclusions: Increased levels of keratin and ankyrin repeat domain 1 protein are
found in patients with CAD, rendering these two proteins as novel biomarkers and
potential drug target for cardiovascular diseases. The speciﬁc molecular mechanisms
require future studies.
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